Citations for
1VCAN, WGN1
Homozygous Recessive Versican Missense Variation Is Associated With Early Teeth Loss in a Pakistani Family.
Bigoni S, Neri M, Scotton C, Farina R, Sabatelli P, Jiang C, Zhang J, Falzarano MS, Rossi R, Ognibene D, Selvatici R, Gualandi F, Bosshardt D, Perri P, Campa C, Brancati F, Salvatore M, De Stefano MC, Taruscio D, Trombelli L, Fang M, Ferlini A.
Front Genet 9:723. doi: 10.3389/fgene.2018.00723. eCollection 2018. 2019
2VCAN, WGN1
VCAN Canonical Splice Site Mutation is Associated With Vitreoretinal Degeneration and Disrupts an MMP Proteolytic Site.
Tang PH, Velez G, Tsang SH, Bassuk AG, Mahajan VB.
Invest Ophthalmol Vis Sci 60(1):282-293. doi: 10.1167/iovs.18-25624. 2019
3PAPSSS2, SNAI1, VCAN
Enhanced PAPSS2/VCAN sulfation axis is essential for Snail-mediated breast cancer cell migration and metastasis.
Zhang Y, Zou X, Qian W, Weng X, Zhang L, Zhang L, Wang S, Cao X, Ma L, Wei G, Wu Y, Hou Z.
Cell Death Differ 26(3):565-579. doi: 10.1038/s41418-018-0147-y. Epub 2018 Jun 28. 2019
4VCAN
Identification of critical genes to predict recurrence and death in colon cancer: integrating gene expression and bioinformatics analysis.
Long X, Deng Z, Li G, Wang Z.
Cancer Cell Int 18:139. doi: 10.1186/s12935-018-0640-x. eCollection 2018. 2018
5VCAN, WGN1
Is exon 8 the most critical or the only dispensable exon of the VCAN gene? Insights into VCAN variants and clinical spectrum of Wagner syndrome.
Ankala A, Jain N, Hubbard B, Alexander JJ, Shankar SP.
Am J Med Genet A 176(8):1778-1783. doi: 10.1002/ajmg.a.38855. Epub 2018 Jul 28. 2018
6VCAN
Versican is produced by Trif- and type I interferon-dependent signaling in macrophages and contributes to fine control of innate immunity in lungs.
Chang MY, Kang I, Gale M Jr, Manicone AM, Kinsella MG, Braun KR, Wigmosta T, Parks WC, Altemeier WA, Wight TN, Frevert CW.
Am J Physiol Lung Cell Mol Physiol 313(6):L1069-L1086. doi: 10.1152/ajplung.00353.2017. Epub 2017 Sep 14. 2017
7VCAN
Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma.
Mitsui Y, Shiina H, Kato T, Maekawa S, Hashimoto Y, Shiina M, Imai-Sumida M, Kulkarni P, Dasgupta P, Wong RK, Hiraki M, Arichi N, Fukuhara S, Yamamura S, Majid S, Saini S, Deng G, Dahiya R, Nakajima K, Tanaka Y.
Mol Cancer Res 15(7):884-895. doi: 10.1158/1541-7786.MCR-16-0444. Epub 2017 Feb 27. 2017
8VCAN
Role of Versican and ADAMTS-1 in Polycystic Ovary Syndrome.
Özler S, Öztaş E, Tokmak A, Ergin M, Kuru Pekcan M, Gümüş Güler B, Yakut Hİ, Yılmaz N.
J Clin Res Pediatr Endocrinol 9(1):24-30. doi: 10.4274/jcrpe.3414. Epub 2016 Dec 2. 2017
9VCAN
G1 Domain of Versican Regulates Hyaluronan Organization and the Phenotype of Cultured Human Dermal Fibroblasts.
Merrilees MJ, Zuo N, Evanko SP, Day AJ, Wight TN.
J Histochem Cytochem 64(6):353-63. doi: 10.1369/0022155416643913. Epub 2016 Apr 28. 2016
10VCAN
Versican: a novel modulator of hepatic fibrosis.
Bukong TN, Maurice SB, Chahal B, Schaeffer DF, Winwood PJ.
Lab Invest 96(3):361-74. doi: 10.1038/labinvest.2015.152. Epub 2016 Jan 11. 2016
11VCAN
Versican localizes to the nucleus in proliferating mesenchymal cells.
Carthy JM, Abraham T, Meredith AJ, Boroomand S, McManus BM.
Cardiovasc Pathol 24(6):368-74. doi: 10.1016/j.carpath.2015.07.010. Epub 2015 Aug 7. 2015
12VCAN
A role for versican in the development of leiomyosarcoma.
Keire PA, Bressler SL, Lemire JM, Edris B, Rubin BP, Rahmani M, McManus BM, van de Rijn M, Wight TN.
J Biol Chem 289(49):34089-103. doi: 10.1074/jbc.M114.607168. Epub 2014 Oct 15. 2014
13VCAN
Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.
Desjardins M, Xie J, Gurler H, Muralidhar GG, Sacks JD, Burdette JE, Barbolina MV.
J Ovarian Res 7:70. doi: 10.1186/1757-2215-7-70. eCollection 2014. 2014
14ADAMTS5, SMAD2, VCAN
Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves.
Dupuis LE, Osinska H, Weinstein MB, Hinton RB, Kern CB.
J Mol Cell Cardiol 60:50-9. doi: 10.1016/j.yjmcc.2013.03.010. Epub 2013 Mar 24. 2013
15VCAN
Versican V2 isoform enhances angiogenesis by regulating endothelial cell activities and fibronectin expression.
Yang W, Yee AJ.
FEBS Lett 587(2):185-92. doi: 10.1016/j.febslet.2012.11.023. Epub 2012 Nov 28. 2013
16DSPP, MEPE, OGN, VCAN
Developmental changes and regional localization of Dspp, Mepe, Mimecan and Versican in postnatal developing mouse teeth.
Hou C, Liu ZX, Tang KL, Wang MG, Sun J, Wang J, Li S.
J Mol Histol 43(1):9-16. doi: 10.1007/s10735-011-9368-9. Epub 2011 Nov 1. 2012
17ADAMTS1, FBLN1, VCAN
Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferation.
Cooley MA, Fresco VM, Dorlon ME, Twal WO, Lee NV, Barth JL, Kern CB, Iruela-Arispe ML, Argraves WS.
Dev Dyn 241(2):303-14. doi: 10.1002/dvdy.23716. Epub 2011 Dec 19. 2012
18VCAN
Inhibition of hyaluronan synthesis reduces versican and fibronectin levels in trabecular meshwork cells.
Keller KE, Sun YY, Vranka JA, Hayashi L, Acott TS.
PLoS One 7(11):e48523. doi: 10.1371/journal.pone.0048523. Epub 2012 Nov 5. 2012
19VCAN, WGN1
A new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features.
Brézin AP, Nedelec B, Barjol A, Rothschild PR, Delpech M, Valleix S.
Mol Vis. 17:1669-78. 2011
20VCAN
Versican facilitates chondrocyte differentiation and regulates joint morphogenesis.
Choocheep K, Hatano S, Takagi H, Watanabe H, Kimata K, Kongtawelert P, Watanabe H.
J Biol Chem. 285(27):21114-25. 2010
21VCAN
Structure and regulation of the versican promoter: the versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells.
Domenzain-Reyna C, Hernández D, Miquel-Serra L, Docampo MJ, Badenas C, Fabra A, Bassols A.
J Biol Chem 284(18):12306-17. Epub 2009 Mar 6. 2009
22VCAN
Association analysis of genes involved in the maintenance of the integrity of the extracellular matrix with intracranial aneurysms in a Japanese cohort.
Ruigrok YM, Rinkel GJ, Wijmenga C, Kasuya H, Tajima A, Takahashi T, Hata A, Inoue I, Krischek B.
Cerebrovasc Dis 28(2):131-4. Epub 2009 Jun 5. 2009
23VCAN
Versican overexpression in cutaneous malignant melanoma.
Gambichler T, Kreuter A, Grothe S, Altmeyer P, Brockmeyer NH, Rotterdam S.
Eur J Med Res 13(11):500-4. 2008
24VCAN
Versican, a major hyaluronan-binding component in the dermis, loses its hyaluronan-binding ability in solar elastosis.
Hasegawa K, Yoneda M, Kuwabara H, Miyaishi O, Itano N, Ohno A, Zako M, Isogai Z.
J Invest Dermatol 127(7):1657-63. Epub 2007 Mar 15. 2007
25VCAN
Versican expression in human cervical cancer.
Kodama J, Hasengaowa, Kusumoto T, Seki N, Matsuo T, Nakamura K, Hongo A, Hiramatsu Y.
Eur J Cancer 43(9):1460-6. Epub 2007 Apr 18. 2007
26WGN1, VCAN
Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants.
Mukhopadhyay A, Nikopoulos K, Maugeri A, de Brouwer AP, van Nouhuys CE, Boon CJ, Perveen R, Zegers HA, Wittebol-Post D, van den Biesen PR, van der Velde-Visser SD, Brunner HG, Black GC, Hoyng CB, Cremers FP.
Invest Ophthalmol Vis Sci 47(8):3565-72. 2006
27WGN1, VCAN
Identification of the genetic defect in the original Wagner syndrome family.
Kloeckener-Gruissem B, Bartholdi D, Abdou MT, Zimmermann DR, Berger W.
Mol Vis 12:350-5. 2006
28VCAN
Versican mediates mesenchymal-epithelial transition.
Sheng W, Wang G, La Pierre DP, Wen J, Deng Z, Wong CK, Lee DY, Yang BB.
Mol Biol Cell 17(4):2009-20. Epub 2006 Feb 1. 2006
29VCAN, WGN1
Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome.
Miyamoto T, Inoue H, Sakamoto Y, Kudo E, Naito T, Mikawa T, Mikawa Y, Isashiki Y, Osabe D, Shinohara S, Shiota H, Itakura M.
Invest Ophthalmol Vis Sci 46(8):2726-35. 2005
30VCAN
Versican splice variants in human trabecular meshwork and ciliary muscle.
Zhao X, Russell P.
Mol Vis 11:603-8. 2005
31ADAMTS4, VCAN
ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein.
Westling J, Gottschall PE, Thompson VP, Cockburn A, Perides G, Zimmermann DR, Sandy JD.
Biochem J 377(Pt 3):787-95. 2004
32VCAN
PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation.
Zheng PS, Vais D, Lapierre D, Liang YY, Lee V, Yang BL, Yang BB.
J Cell Sci. 117(Pt 24):5887-95. 2004
33VCAN
Distinct interaction of versican/PG-M with hyaluronan and link protein.
Matsumoto K, Shionyu M, Go M, Shimizu K, Shinomura T, Kimata K, Watanabe H.
J Biol Chem. 278(42):41205-12. 2003
34VCAN
Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks.
Isogai Z, Aspberg A, Keene DR, Ono RN, Reinhardt DP, Sakai LY.
J Biol Chem. 277(6):4565-72. 2002
35VCAN
beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican.
Wu Y, Chen L, Zheng PS, Yang BB.
J Biol Chem. 277(14):12294-301 2002
36VCAN
Versican interacts with chemokines and modulates cellular responses.
Hirose J, Kawashima H, Yoshie O, Tashiro K, Miyasaka M
J Biol Chem. 276(7):5228-34. 2001
37VCAN
The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding.
Olin AI, Mörgelin M, Sasaki T, Timpl R, Heinegĺrd D, Aspberg A.
J Biol Chem. 276(2):1253-61. 2001
38VCAN
Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.
Kawashima H, Hirose M, Hirose J, Nagakubo D, Plaas AH, Miyasaka M.
J Biol Chem. 275(45):35448-56. 2000
39HAPLN1, VCAN, WVR, WGN1
Refined genetic and physical localization of the Wagner disease (WGN1) locus and the genes CRTL1 and CSPG2 to a 2- to 2.5-cM region of chromosome 5q14.3.
Perveen R, et al.
Genomics 57(2):219-26. 1999
40VRD1, WGN1, VCAN
A novel hereditary developmental vitreoretinopathy with multiple ocular abnormalities localizing to a 5-cM region of chromosome 5q13-q14.
Black GC, Perveen R, Wiszniewski W, Dodd CL, Donnai D, McLeod D.
Ophthalmology 106(11):2074-81 1999
41VCAN
Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican.
Aspberg A, Adam S, Kostka G, Timpl R, Heinegĺrd D.
J Biol Chem. 274(29):20444-9. 1999
42VCAN
Distribution of the large aggregating proteoglycan versican in adult human tissues.
Bode-Lesniewska B, Dours-Zimmermann MT, Odermatt BF, Briner J, Heitz PU, Zimmermann DR.
J Histochem Cytochem. 44(4):303-12. 1996
43WVR, SET, WGN1, VCAN
Genetic linkage of Wagner disease and erosive vitreoretinopathy to chromosome 5q13-14.
Brown DM, et al.
Arch Ophthalmol 113 : 671-675. 1995
44VCAN
Expression of PG-M(V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues.
Zako M, Shinomura T, Ujita M, Ito K, Kimata K.
J Biol Chem 270(8):3914-8. 1995
45VCAN
A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican.
Dours-Zimmermann MT, Zimmermann DR.
J Biol Chem 269(52):32992-8. 1994
46VCAN
Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter.
Naso MF, Zimmermann DR, Iozzo RV.
J Biol Chem 269(52):32999-3008. 1994
47VCAN
Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14).
Iozzo RV, et al.
Genomics 14 : 845-851. 1992
48VCAN
Multiple domains of the large fibroblast proteoglycan, versican.
Zimmermann DR, Ruoslahti E.
EMBO J 8(10):2975-81. 1989
49VCAN
A fibroblast chondroitin sulfate proteoglycan core protein contains lectin-like and growth factor-like sequences.
Krusius T, Gehlsen KR, Ruoslahti E.
J Biol Chem 262(27):13120-5. 1987